FDA approves First RSV vaccine for adults under 60

FDA Expands Approval of RSV Vaccine Abrysvo to Include All At-Risk Adults
The FDA expanded the approval of the bivalent RSV prefusion F (RSVpreF) vaccine (Abrysvo) to include the prevention of lower respiratory tract disease (LRTD) caused by respiratory syncytial virus (RSV) in high-risk adults ages 18 to 59 years, Pfizer announced on Tuesday.
US FDA approves Pfizer's RSV vaccine for adults at increased risk of the disease
The U.S. Food and Drug Administration on Tuesday approved Pfizer's RSV vaccine for the prevention of lower respiratory tract disease caused by RSV in adults aged 18 to 59 at increased risk of the disease.
Pfizer’s RSV vaccine cleared by FDA for use in some younger adults
Approval of Pfizer's Abrysvo in certain adults aged 18 to 59 years old will substantially expand the number of people eligible for vaccination with the shot.
FDA Approves Abrysvo RSV Vaccine for Adults at Increased Risk
Abrysvo is the first and only respiratory syncytial virus (RSV) vaccine indicated for adults younger than 50 years.
Pfizer Receives FDA Approval for RSV Vaccine
Abrysvo can prevent lower respiratory tract disease caused by RSV for people between the ages of 18 and 59 who are at increased risk. It is the first RSV vaccine indicated for adults younger than 50,
PFE Gets FDA Nod for Expanded Use of RSV Vaccine Abrysvo
Pfizer Inc. PFE announced that the FDA has granted approval for the expanded use of its respiratory syncytial virus (RSV) vaccine, Abrysvo, in adults aged 18-59 years. The vaccine has been approved for the prevention of lower respiratory tract disease (LRTD) caused by RSV in patients aged 18-59 years who are at increased risk of the disease.
FDA approves 1st RSV vaccine for adults under 60
The expansion builds on the previous indication for adults 60 years and older. The vaccine is also approved for pregnant individuals to protect infants from birth up to six months. With the decision,
HHS spent $911M on COVID vaccine messaging, ‘consistently overstated’ virus risk to kids, damning House report finds
The campaign “caused Americans to lose trust in the public health system,” House Energy and Commerce Committee Chair Cathy ...
Vaccine for winter vomiting bug to be trialled on thousands
A vaccine is to be trialled on thousands of people to find out if it could protect against norovirus - a stomach bug that ...
UK testing 'world first' vaccine for norovirus vomiting bug, aiming to curb burden on health system
The late-stage trial will recruit about 25,000 people around the world to test the new vaccine from Moderna.View on euronews ...
Why are millions more New Yorkers getting a flu shot than the COVID vaccine? What we know.
Nearly 10.4M New Yorkers, or 53%, got the flu shot last year. Only about 12% got the COVID shot. Here's why, how officials ...
World’s first vaccine for winter vomiting bug norovirus to be trialled in UK
He said: “The UK is leading the way to develop a world-first vaccine for this vomiting bug, starting with this innovative ...
Covid vaccine – our fight for compensation
The BBC's Fergus Walsh hears from those calling for the payment system set up to help those left disabled after having a ...
Psychology Today1d
A Vaccine Against Fentanyl!
A vaccine against fentanyl—yes! Finally, a truly novel approach to SUDs is currently under development and hopefully will ...
Norovirus vaccine based on same tech that beat Covid to be trialled across Britain
A norovirus vaccine based on the mRNA technology that helped to defeat Covid will be trialled in the UK for the first time, ...
Covid Vaccine: Fighting for a Payout
The Oxford AstraZeneca vaccine is credited with saving millions of lives but it was also responsible, in rare cases, for ...